Skip to main content
Premium Trial:

Request an Annual Quote

European Genetic Disorder Effort Using CLC Bio's Genomics Workbench

NEW YORK (GenomeWeb News) – A pan-European effort to develop diagnostics for a range of genetic disorders will work with CLC Bio to develop high-throughput sequencing and analysis technologies, the Danish company said today.

The EU-funded Techgene project collaborators will use the Genomics Workbench in its effort to incorporate massively parallel sequencing in routine diagnostic labs. The project will focus on a number of model disorders that have shown varying degrees of genetic complexity, such as hereditary breast cancer, ataxias, mental retardation, and sensory diseases such as blindness and deafness.

"Being part of the Techgene project provides an excellent opportunity to develop a solid solution for diagnostics using amplicon high throughput resequencing in conjunction with some of the most esteemed institutions," Patrick Dekker, a senior bioinformatics specialist at CLC Bio, said in a statement.

Dekker said that the software workbench will provide the researchers with the capacity to diagnose patients based on chromosomal and gene regions, to locate SNPs, deletion and insertion polymorphisms, and copy number variations.

Financial terms of the agreement were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.